Newsbenzinga
Harrow Re-Launches Steroid-Sparing VERKAZIA For Vernal Keratoconjunctivitis, Targeting Underlying Inflammatory Mechanisms In Pediatric Patients
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…